|
|
Article: North American Vaccine, Inc. Raises Additional $11.25 Million from Exercise of Overallotment Option.
- Article from:
- Business Wire
- Article date:
- May 3, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BELTSVILLE, Md.--(BUSINESS WIRE)--May 3, 1996--North American Vaccine, Inc. (AMEX: NVX) announced today that the initial purchasers of its 6.5% Convertible Subordinated Notes due May 1, 2003 have exercised their over-allotment option to purchase an additional $11.25 million principal amount of the Notes. The exercise of the over-allotment option brings the total gross proceeds from the placement of the Notes to $86.25 million. The closing on the sale of the Notes is expected to occur on May 7, 1996.
As earlier announced, the Notes being offered are not registered under the Securities Act ...